Original
Prevalencia de síndrome metabólico en pacientes con enfermedad coronaria estable: objetivos terapéuticos y utilización de fármacos cardiovasculares
Prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs
C. Lahoza,
, J.M. Mostazaa, M.T. Mantillab, M. Taboadac, S. Tranched, I. López-Rodrígueze, B. Monteirof, M.A. Sánchez-Zamoranof, R. Martín-Jadraquea
Corresponding author
a Unidad de Arteriosclerosis, Hospital Carlos III, Madrid, España
b Centro de Salud Mar Báltico, Madrid, España
c Centro de Salud Fuencarral, Madrid, España
d Centro de Salud El Cristo, Oviedo, España
e Centro de Salud de Begonte, Lugo, España
f Cardiovascular Department, Bristol-Myers-Squibb, Madrid, España
Read
74
Timeswas read the article
74
Total PDF
0
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 4 | 4 |
| 2025 10 | 0 | 1 | 1 |
| 2025 9 | 0 | 4 | 4 |
| 2025 8 | 0 | 2 | 2 |
| 2025 7 | 0 | 1 | 1 |
| 2025 6 | 0 | 1 | 1 |
| 2025 3 | 0 | 2 | 2 |
| 2025 2 | 0 | 1 | 1 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 4 | 4 |
| 2024 11 | 0 | 1 | 1 |
| 2024 10 | 0 | 1 | 1 |
| 2024 9 | 0 | 2 | 2 |
| 2024 8 | 0 | 1 | 1 |
| 2024 7 | 0 | 3 | 3 |
| 2024 5 | 0 | 1 | 1 |
| 2024 3 | 0 | 7 | 7 |
| 2024 2 | 0 | 6 | 6 |
| 2024 1 | 0 | 5 | 5 |
| 2023 12 | 0 | 11 | 11 |
| 2023 11 | 0 | 4 | 4 |
| 2023 10 | 0 | 5 | 5 |
| 2023 7 | 0 | 3 | 3 |
| 2023 6 | 0 | 2 | 2 |
Show all
